CEGEDIM SA (CGM.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:CGM - FR0000053506 - Common Stock
10.4 EUR
-0.2 (-1.89%)
CGM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 11 industry peers in the Health Care Technology industry. CGM may be in some trouble as it scores bad on both profitability and health. CGM has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CGM has reported negative net income.
In the past year CGM had a positive cash flow from operations.
In multiple years CGM reported negative net income over the last 5 years.
Each year in the past 5 years CGM had a positive operating cash flow.
1.2 Ratios
CGM has a Return On Assets (-1.49%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -5.56%, CGM is in line with its industry, outperforming 45.45% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 4.46%, CGM is in line with its industry, outperforming 45.45% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CGM is significantly below the industry average of 9.17%.
The 3 year average ROIC (2.87%) for CGM is below the current ROIC(4.46%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.49% | ||
| ROE | -5.56% | ||
| ROIC | 4.46% |
ROA(3y)-0.25%
ROA(5y)0.74%
ROE(3y)-1.16%
ROE(5y)2.61%
ROIC(3y)2.87%
ROIC(5y)3.89%
1.3 Margins
With a Operating Margin value of 5.75%, CGM perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
CGM's Operating Margin has declined in the last couple of years.
CGM has a worse Gross Margin (20.07%) than 81.82% of its industry peers.
CGM's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.75% | ||
| PM (TTM) | N/A | ||
| GM | 20.07% |
OM growth 3Y-6.64%
OM growth 5Y-3.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.96%
GM growth 5Y-1.7%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CGM is still creating some value.
The number of shares outstanding for CGM has been increased compared to 1 year ago.
The number of shares outstanding for CGM has been reduced compared to 5 years ago.
CGM has a worse debt/assets ratio than last year.
2.2 Solvency
CGM has an Altman-Z score of 1.27. This is a bad value and indicates that CGM is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.27, CGM is in line with its industry, outperforming 45.45% of the companies in the same industry.
CGM has a debt to FCF ratio of 27.31. This is a negative value and a sign of low solvency as CGM would need 27.31 years to pay back of all of its debts.
CGM's Debt to FCF ratio of 27.31 is in line compared to the rest of the industry. CGM outperforms 54.55% of its industry peers.
CGM has a Debt/Equity ratio of 1.14. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.14, CGM is doing worse than 72.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 27.31 | ||
| Altman-Z | 1.27 |
ROIC/WACC1.08
WACC4.14%
2.3 Liquidity
A Current Ratio of 0.99 indicates that CGM may have some problems paying its short term obligations.
The Current ratio of CGM (0.99) is worse than 63.64% of its industry peers.
A Quick Ratio of 0.97 indicates that CGM may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.97, CGM is doing worse than 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.99 | ||
| Quick Ratio | 0.97 |
3. Growth
3.1 Past
CGM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -97.97%.
The Revenue has been growing slightly by 6.25% in the past year.
Measured over the past years, CGM shows a small growth in Revenue. The Revenue has been growing by 5.38% on average per year.
EPS 1Y (TTM)-97.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1194.13%
Revenue 1Y (TTM)6.25%
Revenue growth 3Y7.65%
Revenue growth 5Y5.38%
Sales Q2Q%6.51%
3.2 Future
The Earnings Per Share is expected to grow by 21.86% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 3.41% on average over the next years.
EPS Next Y-1.77%
EPS Next 2Y20.1%
EPS Next 3Y21.86%
EPS Next 5YN/A
Revenue Next Year1.46%
Revenue Next 2Y2.88%
Revenue Next 3Y3.41%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CGM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 9.28, which indicates a very decent valuation of CGM.
CGM's Price/Forward Earnings ratio is rather cheap when compared to the industry. CGM is cheaper than 90.91% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 35.40. CGM is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 9.28 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CGM is valued cheaper than 100.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CGM is valued cheaply inside the industry as 90.91% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.29 | ||
| EV/EBITDA | 3.23 |
4.3 Compensation for Growth
CGM's earnings are expected to grow with 21.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.1%
EPS Next 3Y21.86%
5. Dividend
5.1 Amount
CGM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:CGM (9/3/2025, 7:00:00 PM)
10.4
-0.2 (-1.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners17.29%
Inst Owner ChangeN/A
Ins Owners57.12%
Ins Owner ChangeN/A
Market Cap146.64M
Revenue(TTM)654.50M
Net Income(TTM)-14.71M
Analysts48.89
Price Target12.92 (24.23%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.56%
PT rev (3m)-7.32%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-24.49%
EPS NY rev (3m)-24.49%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 9.28 | ||
| P/S | 0.22 | ||
| P/FCF | 12.29 | ||
| P/OCF | 1.44 | ||
| P/B | 0.55 | ||
| P/tB | N/A | ||
| EV/EBITDA | 3.23 |
EPS(TTM)-1.07
EYN/A
EPS(NY)1.12
Fwd EY10.78%
FCF(TTM)0.85
FCFY8.14%
OCF(TTM)7.22
OCFY69.45%
SpS46.42
BVpS18.75
TBVpS-11.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.49% | ||
| ROE | -5.56% | ||
| ROCE | 6.06% | ||
| ROIC | 4.46% | ||
| ROICexc | 4.84% | ||
| ROICexgc | 19.22% | ||
| OM | 5.75% | ||
| PM (TTM) | N/A | ||
| GM | 20.07% | ||
| FCFM | 1.82% |
ROA(3y)-0.25%
ROA(5y)0.74%
ROE(3y)-1.16%
ROE(5y)2.61%
ROIC(3y)2.87%
ROIC(5y)3.89%
ROICexc(3y)3.13%
ROICexc(5y)4.15%
ROICexgc(3y)11.62%
ROICexgc(5y)15.26%
ROCE(3y)3.91%
ROCE(5y)5.29%
ROICexgc growth 3Y0.21%
ROICexgc growth 5Y-3.19%
ROICexc growth 3Y-3.24%
ROICexc growth 5Y-2.52%
OM growth 3Y-6.64%
OM growth 5Y-3.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.96%
GM growth 5Y-1.7%
F-Score3
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 27.31 | ||
| Debt/EBITDA | 2.3 | ||
| Cap/Depr | 96.22% | ||
| Cap/Sales | 13.74% | ||
| Interest Coverage | 4.24 | ||
| Cash Conversion | 77.7% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.99 | ||
| Quick Ratio | 0.97 | ||
| Altman-Z | 1.27 |
F-Score3
WACC4.14%
ROIC/WACC1.08
Cap/Depr(3y)92.57%
Cap/Depr(5y)94.88%
Cap/Sales(3y)13.24%
Cap/Sales(5y)13.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-97.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1194.13%
EPS Next Y-1.77%
EPS Next 2Y20.1%
EPS Next 3Y21.86%
EPS Next 5YN/A
Revenue 1Y (TTM)6.25%
Revenue growth 3Y7.65%
Revenue growth 5Y5.38%
Sales Q2Q%6.51%
Revenue Next Year1.46%
Revenue Next 2Y2.88%
Revenue Next 3Y3.41%
Revenue Next 5YN/A
EBIT growth 1Y79.81%
EBIT growth 3Y0.5%
EBIT growth 5Y1.66%
EBIT Next Year278.79%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-46.81%
FCF growth 3Y-27.43%
FCF growth 5YN/A
OCF growth 1Y4.01%
OCF growth 3Y2%
OCF growth 5Y28.33%
CEGEDIM SA / CGM.PA FAQ
What is the fundamental rating for CGM stock?
ChartMill assigns a fundamental rating of 3 / 10 to CGM.PA.
Can you provide the valuation status for CEGEDIM SA?
ChartMill assigns a valuation rating of 5 / 10 to CEGEDIM SA (CGM.PA). This can be considered as Fairly Valued.
What is the profitability of CGM stock?
CEGEDIM SA (CGM.PA) has a profitability rating of 3 / 10.
How sustainable is the dividend of CEGEDIM SA (CGM.PA) stock?
The dividend rating of CEGEDIM SA (CGM.PA) is 0 / 10 and the dividend payout ratio is 0%.